Literature DB >> 19808284

GLP-1 therapy: beyond glucose control.

Derek J Hausenloy, Derek M Yellon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19808284     DOI： 10.1161/CIRCHEARTFAILURE.108.810887

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  14 in total

1.  Gastric bypass surgery elevates NT-ProBNP levels.

Authors:  Niclas Abrahamsson; Britt Edén Engström; Magnus Sundbom; F Anders Karlsson
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

2.  Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.

Authors:  G Schernthaner; A H Barnett; D J Betteridge; R Carmena; A Ceriello; B Charbonnel; M Hanefeld; R Lehmann; M T Malecki; R Nesto; V Pirags; A Scheen; J Seufert; A Sjohölm; A Tsatsoulis; R DeFronzo
Journal:  Diabetologia       Date:  2010-03-31       Impact factor: 10.122

3.  Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy.

Authors:  Arpita Kalla Vyas; Kai-Chien Yang; Dennis Woo; Anatoly Tzekov; Attila Kovacs; Patrick Y Jay; Paul W Hruz
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

4.  Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart.

Authors:  Karpagam Aravindhan; Weike Bao; Mark R Harpel; Robert N Willette; John J Lepore; Beat M Jucker
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

5.  L-glutamine supplementation prevents the development of experimental diabetic cardiomyopathy in streptozotocin-nicotinamide induced diabetic rats.

Authors:  Sachin L Badole; Ganesh B Jangam; Swapnil M Chaudhari; Arvindkumar E Ghule; Anand A Zanwar
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

6.  DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes.

Authors:  Hui-Chun Ku; Wen-Pin Chen; Ming-Jai Su
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

7.  Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside.

Authors:  Hector A Cabrera-Fuentes; Corina Alba-Alba; Julian Aragones; Jürgen Bernhagen; William A Boisvert; Hans E Bøtker; Gabriela Cesarman-Maus; Ingrid Fleming; David Garcia-Dorado; Sandrine Lecour; Elisa Liehn; Michael S Marber; Nephtali Marina; Manuel Mayr; Oscar Perez-Mendez; Tetsuji Miura; Marisol Ruiz-Meana; Eduardo M Salinas-Estefanon; Sang-Bing Ong; Hans J Schnittler; Jose T Sanchez-Vega; Adriana Sumoza-Toledo; Carl-Wilhelm Vogel; Dina Yarullina; Derek M Yellon; Klaus T Preissner; Derek J Hausenloy
Journal:  Basic Res Cardiol       Date:  2015-12-14       Impact factor: 17.165

8.  Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.

Authors:  Derek J Hausenloy; Hannah J Whittington; Abigail M Wynne; Shah S Begum; Louise Theodorou; Niels Riksen; Mihaela M Mocanu; Derek M Yellon
Journal:  Cardiovasc Diabetol       Date:  2013-10-22       Impact factor: 9.951

9.  The Dose-Dependent Organ-Specific Effects of a Dipeptidyl Peptidase-4 Inhibitor on Cardiovascular Complications in a Model of Type 2 Diabetes.

Authors:  Ju-Young Moon; Jong Shin Woo; Jung-Woo Seo; Arah Lee; Dong Jin Kim; Yang-Gyun Kim; Se-Yeun Kim; Kyung Hye Lee; Sung-Jig Lim; Xian Wu Cheng; Sang-Ho Lee; Weon Kim
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

Review 10.  Reducing myocardial infarct size: challenges and future opportunities.

Authors:  Heerajnarain Bulluck; Derek M Yellon; Derek J Hausenloy
Journal:  Heart       Date:  2015-12-16       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.